WallStreetZenWallStreetZen

NASDAQ: DERM
Journey Medical Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DERM past revenue growth

How has DERM's revenue growth performed historically?
Company
7.48%
Industry
10.58%
Market
17.3%
DERM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DERM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DERM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DERM earnings and revenue history

Current Revenue
$79.2M
Current Earnings
-$3.9M
Current Profit Margin
-4.9%

DERM Return on Equity

Current Company
-34.1%
Current Industry
15.4%
Current Market
188%
DERM's Return on Equity (-34.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DERM announces earnings.

DERM Return on Assets

Current Company
-5%
Current Industry
3.4%
DERM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DERM Return on Capital Employed

Current Company
-5.53%
Current Industry
5.1%
DERM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DERM vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DERM$79.18M$1.92M-$3.85M+22.71%N/A
SCYX$140.14M$70.89M$67.04M+252.64%N/A
EGRX$257.55M$57.18M$11.95M+3.61%-14.47%
RGC$0.00-$5.10M-$5.87MN/AN/A
TKNO$36.68M-$30.45M-$36.78M+16.24%N/A
View Top Pharmaceutical Stocks

DERM earnings dates

Next earnings date
Jun 25, 2024

Journey Medical Earnings & Revenue FAQ

What were DERM's earnings last quarter?

On Invalid Date, Journey Medical (NASDAQ: DERM) reported Q4 2023 earnings per share (EPS) of -$0.12, up 80% year over year. Total Journey Medical earnings for the quarter were -$2.14 million. In the same quarter last year, Journey Medical's earnings per share (EPS) was -$0.60.

If you're new to stock investing, here's how to buy Journey Medical stock.

What was DERM's earnings growth in the past year?

As of Q2 2024, Journey Medical's earnings has grown year over year. Journey Medical's earnings in the past year totalled -$3.85 million.

What is DERM's earnings date?

Journey Medical's earnings date is Invalid Date. Add DERM to your watchlist to be reminded of DERM's next earnings announcement.

What was DERM's revenue last quarter?

On Invalid Date, Journey Medical (NASDAQ: DERM) reported Q4 2023 revenue of $15.26 million up 4.44% year over year. In the same quarter last year, Journey Medical's revenue was $15.97 million.

What was DERM's revenue growth in the past year?

As of Q2 2024, Journey Medical's revenue has grown 7.48% year over year. This is 3.1 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.58%. Journey Medical's revenue in the past year totalled $79.18 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.